Skip to main content

Table 1 Interview participant and care recipient demographic characteristics

From: Qualitative assessment of the patient experience of primary hyperoxaluria type 1: an observational study

Characteristics

Patient Interviewees (Adults and Adolescents)

N = 16

Caregiver Interviewees on Behalf of Care Recipients (Children Aged 6–16 Years)

N = 12

Total

N = 28

Sex of interview participant,a n (%)

 Male

8 (50.0)

4 (33.3)

12 (42.9)

 Female

8 (50.0)

8 (66.7)

16 (57.1)

Sex of patientb with PH1 (interview participant in the case of patient interviewees; care recipient in the case of caregiver interviewees), n (%)

 Male

8 (50.0)

6 (50.0)

14 (50.0)

 Female

8 (50.0)

6 (50.0)

14 (50.0)

Patientb age, mean (range), y

25.8 (16–51)

10.1 (6–16)

19.1 (6–51)

Patientb kidney function/status, n (%)

 Normal

6 (37.5)

7 (58.3)

13 (46.4)

 Abnormal (without dialysis or transplantation)

3 (18.8)

2 (16.7)

5 (17.9)

 On dialysis

2 (12.5)c

2 (16.7)

4 (14.3)

 Post-kidney and liver transplantation

5 (31.3)

1 (8.3)

6 (21.4)

Patientb race/ethnicity, n (%)

 White

15 (93.8)

9 (75.0)

24 (85.7)

 Black

1 (6.3)

1 (8.3)

2 (7.1)

 Mixed

0 (0.0)

2 (16.7)

2 (7.1)

 Hispanic or Latino

1 (6.3)

1 (8.3)

2 (7.1)

Interview participant education,a n (%)

 Less than high school

6 (37.5)

0 (0.0)

6 (21.4)

 High school or equivalent

0 (0.0)

2 (16.7)

2 (7.1)

 Associate or technical degree

0 (0.0)

1 (8.3)

1 (3.6)

 Some college but no degree

5 (31.3)

1 (8.3)

6 (21.4)

 College degree

4 (25.0)

7 (58.3)

11 (39.3)

 Graduate or professional degree

1 (6.3)

1 (8.3)

2 (7.1)

  1. aInterview participants are patients > 16 years of age and care providers for patients 6–16 years of age
  2. bIn the case of caregiver interviewees, “patient” refers to the patient with PH1 who is being cared for by the interviewee
  3. cIncludes 1 participant who reported previous experience with dialysis but, due to improvements in kidney function, has now been able to stop dialysis treatments. For the purposes of the report, this participant is included in the dialysis treatment group